The Role Of Cytokines In Irritable Bowel Syndrome: Review Article

Abstract

(IBS) or Irritable bowel syndrome is a complicated health condition with different causative factors, including inflammation and infection, that have recently acquired as significant triggers of IBS. Inflammatory response might serve as a critical pathway in the progression of IBS, beside inequality in cytokines within the plasma and/or intestinal mucosal lining. Many biomarkers have been associated to possible mechanisms underlying IBS and are used to make differentiation between IBS and non-IBS subjects. Incorporation of these biomarkers into routine clinical work is important for fast and accurate diagnosis and effective treatment. Because IBS patients often experience ambiguous and overlapping symptoms, the creation of precise biomarkers for IBS could significantly enhance both diagnosis and patient care. This review examines the cytokines used in the diagnosis and treatment of IBS, Classifying these cytokines as either pro-inflammatory or anti-inflammatory and understanding their involvement in the development of irritable bowel syndrome.